Skip to content
CIMT 2021 – Identification of shared tumor epitopes from endogenous retroviruses inducing high avidity cytotoxic T cells for cancer immunotherapy
Home/Publications & abstracts/CIMT 2021 – Identification of shared tumor epitopes from endogenous retroviruses inducing high avidity cytotoxic T cells for cancer immunotherapy
CIMT 2021 – Identification of shared tumor epitopes from endogenous retroviruses inducing high avidity cytotoxic T cells for cancer immunotherapy
webmaster@ervaccinetechnologies.com2021-12-17T09:59:41+00:00
Share on your favorite plateform
Page load link